OTCMKTS:PCYN

Procyon Stock Forecast, Price & News

$0.60
-0.10 (-14.29 %)
(As of 04/14/2021 01:39 PM ET)
Add
Compare
Today's Range
$0.60
Now: $0.60
$0.60
50-Day Range
$0.60
MA: $0.67
$0.80
52-Week Range
$0.18
Now: $0.60
$1.00
Volume3,054 shs
Average Volume4,718 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions under the AMERIGEL brand name. It also provides Bioactive Collagen products under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name; and compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Clearwater, Florida.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PCYN
CUSIP742806300
Phone727-447-2998
Employees18
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.40 out of 5 stars

Medical Sector

1744th out of 2,019 stocks

Drug Manufacturers - Specialty & Generic Industry

59th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.60
-0.10 (-14.29 %)
(As of 04/14/2021 01:39 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PCYN News and Ratings via Email

Sign-up to receive the latest news and ratings for PCYN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Procyon (OTCMKTS:PCYN) Frequently Asked Questions

What stocks does MarketBeat like better than Procyon?

Wall Street analysts have given Procyon a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Procyon wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Procyon's stock been impacted by Coronavirus?

Procyon's stock was trading at $0.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PCYN shares have increased by 140.0% and is now trading at $0.60.
View which stocks have been most impacted by COVID-19
.

Who are Procyon's key executives?

Procyon's management team includes the following people:
  • Mr. Justice W. Anderson, CEO, Pres & Director (Age 44, Pay $269.58k)
  • Mr. James B. Anderson, CFO & Director (Age 51, Pay $182.85k)
  • Mr. George Otis Borak, VP of Sales - Amerx Health Care Corp. (Age 60, Pay $191.96k)

Who are some of Procyon's key competitors?

What other stocks do shareholders of Procyon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Procyon investors own include (CRPB) (CRPB), Aphria (APHA) and Aerie Pharmaceuticals (AERI).

What is Procyon's stock symbol?

Procyon trades on the OTCMKTS under the ticker symbol "PCYN."

How do I buy shares of Procyon?

Shares of PCYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Procyon's stock price today?

One share of PCYN stock can currently be purchased for approximately $0.60.

How many employees does Procyon have?

Procyon employs 18 workers across the globe.

What is Procyon's official website?

The official website for Procyon is procyoncorp.com.

How can I contact Procyon?

The company can be reached via phone at 727-447-2998.


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.